Latest News and Press Releases

Reimbursement granted with no restrictions to the labelAlimera to begin selling later in Q3 ATLANTA, Aug. 09, 2022 (GLOBE NEWSWIRE) -- Alimera Sciences, Inc. (Nasdaq: ALIM) (“Alimera”), a global...

New Preclinical Data Presented at the FOCIS 2022 Annual Meeting Demonstrating Prevention of Type 1 Diabetes in a Stringent Preclinical Model Initial Clinical Results Expected in 2H’22 from Phase 1...

IRVINE, Calif., Aug. 09, 2022 (GLOBE NEWSWIRE) -- Reneo Pharmaceuticals, Inc. (Nasdaq: RPHM), a clinical-stage pharmaceutical company focused on the development and commercialization of therapies...

ST. LOUIS, Aug. 09, 2022 (GLOBE NEWSWIRE) -- Post Holdings, Inc. (NYSE:POST) (the “Company” or “Post”) today announced an underwritten offering (“the offering”) of 14,800,000 shares of common stock...

SEATTLE, Aug. 09, 2022 (GLOBE NEWSWIRE) -- Almas Insight, a company that provides data-driven solutions for organizations to measure needed human skills in the job market, today announces the...

This second 3D, MP microchip Application Seeks to Further Strengthen GBT’s Multi-Dimensional Integrated Circuits Design and Manufacturing Concept SAN DIEGO, Aug. 09, 2022 (GLOBE NEWSWIRE) -- GBT...

Initial PC14586 Phase 1 data presented at the American Society of Clinical Oncology Annual Meeting (ASCO) demonstrated responses in patients across multiple solid tumor types with a p53 Y220C...

HOLLYWOOD, Fla., Aug. 09, 2022 (GLOBE NEWSWIRE) -- NV5 Global, Inc. (the “Company” or “NV5”) (Nasdaq: NVEE), a provider of technology, conformity assessment, and consulting solutions, announced...

- Enrollment Progressing in Phase 1 ADVANCED-1 Study of TARA-002 for the Treatment of Non-Muscle Invasive Bladder Cancer - - Strong Cash, Cash Equivalents and Investments Position of $112.8M as of...

CALGARY, Alberta, Aug. 09, 2022 (GLOBE NEWSWIRE) -- Odyssey Trust Company (“Odyssey” or the “Company”) is pleased to announce the launch of its DTC Eligibility Services program with OTC Advisory...